RaySearch releases RayCare 3B
RaySearch Laboratories AB (publ) announces the release of a new version of RayCare® 3B* with new features and enhancements throughout the system. The oncology information system (OIS) has been developed in partnership with leading oncology centers globally.
RayCare 3B provides new features for managing radiation treatment planning. A plan overview workspace enables further automation of the planning process by utilizing RayCare® workflows and tasks to trigger RayStation®* scripts. Enhanced automation capabilities help reduce the risk of errors, increase treatment planning efficiency, and promote consistency. The new features are also available in the RayCare Flow product license, a productivity package that can be used in co-existence with existing OIS software.
The patient chart has been extended to include workspaces for managing medications, problems and allergies, as well as a comprehensive overview of all patient-related notes and messages. This version offers improved workflow management, task-based offline image review for 2D/3D images, scheduled rules for PACS, and enhanced interoperability with hospital information systems using standardized interfaces.
Eeva-Liisa Karjalainen, Chief Functionality Owner RayCare, RaySearch, says: With the addition of task-based support for scripting we are now in a position to automate all steps in the workflow from planning image acquisition up to treatment plan approval. I am very excited to see how this advanced automation support can transform clinical workflows.”
Johan Löf, founder and CEO, RaySearch, says: “RayCare is developing quickly to provide more comprehensive treatments in RayCare and RayStation, as well as a more integrated user experience. Looking forward, additional updates will be made during 2020 as part of our ongoing drive to connect and support the entire range of treatment technologies available in the fight against cancer.”
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets the RayStation* treatment planning system and RayCare*, the next-generation oncology information system, worldwide. Over 2,600 clinics in more than 65 countries use RaySearch’s software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.
RayCare is designed to support the complex logistical challenges of modern oncology clinics. It represents the future of oncology information system technology, supporting the vision of one oncology workflow. Many cancer patients receive a combination of treatment types, and RayCare is designed to reflect that. It will efficiently coordinate activities in radiation therapy, chemotherapy and surgery and will offer advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy. RayCare is being developed with tomorrow’s requirements for advanced analytics and decision support in mind.
RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare, the next-generation oncology information system. By harmonizing the treatment planning, we enable better care for cancer patients worldwide.
More information about RaySearch is available at www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
For further information, please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59PDF